JPH04305512A - External preparation for skin - Google Patents
External preparation for skinInfo
- Publication number
- JPH04305512A JPH04305512A JP3142298A JP14229891A JPH04305512A JP H04305512 A JPH04305512 A JP H04305512A JP 3142298 A JP3142298 A JP 3142298A JP 14229891 A JP14229891 A JP 14229891A JP H04305512 A JPH04305512 A JP H04305512A
- Authority
- JP
- Japan
- Prior art keywords
- skin
- extract
- melissa
- vitamins
- preparation
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 238000002360 preparation method Methods 0.000 title claims abstract description 18
- 239000000284 extract Substances 0.000 claims abstract description 34
- 241000207923 Lamiaceae Species 0.000 claims abstract description 11
- 241000196324 Embryophyta Species 0.000 claims abstract description 10
- 229940088594 vitamin Drugs 0.000 claims abstract description 10
- 229930003231 vitamin Natural products 0.000 claims abstract description 10
- 235000013343 vitamin Nutrition 0.000 claims abstract description 10
- 239000011782 vitamin Substances 0.000 claims abstract description 10
- 244000062730 Melissa officinalis Species 0.000 claims description 22
- 235000010654 Melissa officinalis Nutrition 0.000 claims description 2
- 241001529735 Melissa Species 0.000 claims 2
- 230000000694 effects Effects 0.000 abstract description 13
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 12
- 230000032683 aging Effects 0.000 abstract description 5
- 239000002932 luster Substances 0.000 abstract description 5
- 238000007665 sagging Methods 0.000 abstract description 5
- 238000010992 reflux Methods 0.000 abstract description 2
- 150000005846 sugar alcohols Polymers 0.000 abstract description 2
- 206010040849 Skin fissures Diseases 0.000 abstract 2
- 238000013329 compounding Methods 0.000 abstract 2
- 238000001914 filtration Methods 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000003491 skin Anatomy 0.000 description 22
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 12
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 11
- 239000006071 cream Substances 0.000 description 10
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 10
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 9
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 8
- -1 acetyl pantothenyl ethyl ether Chemical compound 0.000 description 8
- 239000003205 fragrance Substances 0.000 description 8
- 239000002537 cosmetic Substances 0.000 description 7
- 206010013786 Dry skin Diseases 0.000 description 6
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 6
- 235000011187 glycerol Nutrition 0.000 description 6
- 239000012071 phase Substances 0.000 description 6
- 239000003755 preservative agent Substances 0.000 description 6
- 239000008213 purified water Substances 0.000 description 6
- 239000006210 lotion Substances 0.000 description 5
- 239000000203 mixture Substances 0.000 description 5
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 5
- 239000003921 oil Substances 0.000 description 5
- 230000002335 preservative effect Effects 0.000 description 5
- 229940032094 squalane Drugs 0.000 description 5
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 5
- 229940058015 1,3-butylene glycol Drugs 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 4
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 4
- 235000019437 butane-1,3-diol Nutrition 0.000 description 4
- 235000019198 oils Nutrition 0.000 description 4
- 229960000984 tocofersolan Drugs 0.000 description 4
- 229940099259 vaseline Drugs 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 3
- 239000002202 Polyethylene glycol Substances 0.000 description 3
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 3
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 3
- 239000000839 emulsion Substances 0.000 description 3
- 230000001815 facial effect Effects 0.000 description 3
- 238000004519 manufacturing process Methods 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- 235000001968 nicotinic acid Nutrition 0.000 description 3
- 229920001223 polyethylene glycol Polymers 0.000 description 3
- 150000003839 salts Chemical class 0.000 description 3
- YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 2
- VBICKXHEKHSIBG-UHFFFAOYSA-N 1-monostearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(O)CO VBICKXHEKHSIBG-UHFFFAOYSA-N 0.000 description 2
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 2
- QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 2
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 2
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 2
- 239000011627 DL-alpha-tocopherol Substances 0.000 description 2
- 235000001809 DL-alpha-tocopherylacetate Nutrition 0.000 description 2
- 239000011626 DL-alpha-tocopherylacetate Substances 0.000 description 2
- QZKRHPLGUJDVAR-UHFFFAOYSA-K EDTA trisodium salt Chemical compound [Na+].[Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC([O-])=O)CC([O-])=O QZKRHPLGUJDVAR-UHFFFAOYSA-K 0.000 description 2
- 239000004166 Lanolin Substances 0.000 description 2
- 241000234435 Lilium Species 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- UDRYFKCHZFVZGJ-UHFFFAOYSA-N [5-hexadecanoyloxy-4-(hexadecanoyloxymethyl)-6-methylpyridin-3-yl]methyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC1=CN=C(C)C(OC(=O)CCCCCCCCCCCCCCC)=C1COC(=O)CCCCCCCCCCCCCCC UDRYFKCHZFVZGJ-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- 229940087168 alpha tocopherol Drugs 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000008346 aqueous phase Substances 0.000 description 2
- KVYGGMBOZFWZBQ-UHFFFAOYSA-N benzyl nicotinate Chemical compound C=1C=CN=CC=1C(=O)OCC1=CC=CC=C1 KVYGGMBOZFWZBQ-UHFFFAOYSA-N 0.000 description 2
- FUWUEFKEXZQKKA-UHFFFAOYSA-N beta-thujaplicin Chemical compound CC(C)C=1C=CC=C(O)C(=O)C=1 FUWUEFKEXZQKKA-UHFFFAOYSA-N 0.000 description 2
- 239000004359 castor oil Substances 0.000 description 2
- 235000019438 castor oil Nutrition 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 2
- 239000002552 dosage form Substances 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 description 2
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000004615 ingredient Substances 0.000 description 2
- 229940119170 jojoba wax Drugs 0.000 description 2
- 235000019388 lanolin Nutrition 0.000 description 2
- 229940039717 lanolin Drugs 0.000 description 2
- 238000002156 mixing Methods 0.000 description 2
- 229960003512 nicotinic acid Drugs 0.000 description 2
- 239000011664 nicotinic acid Substances 0.000 description 2
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 2
- NWVVVBRKAWDGAB-UHFFFAOYSA-N p-methoxyphenol Chemical compound COC1=CC=C(O)C=C1 NWVVVBRKAWDGAB-UHFFFAOYSA-N 0.000 description 2
- 239000000419 plant extract Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 description 2
- 229960002477 riboflavin Drugs 0.000 description 2
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 2
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 2
- 229940042585 tocopherol acetate Drugs 0.000 description 2
- 229960005066 trisodium edetate Drugs 0.000 description 2
- 235000005282 vitamin D3 Nutrition 0.000 description 2
- 239000011647 vitamin D3 Substances 0.000 description 2
- QYSXJUFSXHHAJI-YRZJJWOYSA-N vitamin D3 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-YRZJJWOYSA-N 0.000 description 2
- 229940021056 vitamin d3 Drugs 0.000 description 2
- 235000004835 α-tocopherol Nutrition 0.000 description 2
- 239000002076 α-tocopherol Substances 0.000 description 2
- GZIFEOYASATJEH-VHFRWLAGSA-N δ-tocopherol Chemical compound OC1=CC(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-VHFRWLAGSA-N 0.000 description 2
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- MRAMPOPITCOOIN-VIFPVBQESA-N (2r)-n-(3-ethoxypropyl)-2,4-dihydroxy-3,3-dimethylbutanamide Chemical compound CCOCCCNC(=O)[C@H](O)C(C)(C)CO MRAMPOPITCOOIN-VIFPVBQESA-N 0.000 description 1
- CUNWUEBNSZSNRX-RKGWDQTMSA-N (2r,3r,4r,5s)-hexane-1,2,3,4,5,6-hexol;(z)-octadec-9-enoic acid Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O.CCCCCCCC\C=C/CCCCCCCC(O)=O CUNWUEBNSZSNRX-RKGWDQTMSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- FFJCNSLCJOQHKM-CLFAGFIQSA-N (z)-1-[(z)-octadec-9-enoxy]octadec-9-ene Chemical compound CCCCCCCC\C=C/CCCCCCCCOCCCCCCCC\C=C/CCCCCCCC FFJCNSLCJOQHKM-CLFAGFIQSA-N 0.000 description 1
- QMMJWQMCMRUYTG-UHFFFAOYSA-N 1,2,4,5-tetrachloro-3-(trifluoromethyl)benzene Chemical compound FC(F)(F)C1=C(Cl)C(Cl)=CC(Cl)=C1Cl QMMJWQMCMRUYTG-UHFFFAOYSA-N 0.000 description 1
- CRBBOOXGHMTWOC-NPDDRXJXSA-N 1,4-Anhydro-6-O-dodecanoyl-2,3-bis-O-(2-hydroxyethyl)-D-glucitol Chemical compound CCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](OCCO)[C@H]1OCCO CRBBOOXGHMTWOC-NPDDRXJXSA-N 0.000 description 1
- FDCJDKXCCYFOCV-UHFFFAOYSA-N 1-hexadecoxyhexadecane Chemical compound CCCCCCCCCCCCCCCCOCCCCCCCCCCCCCCCC FDCJDKXCCYFOCV-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 1
- SAMYFBLRCRWESN-UHFFFAOYSA-N 16-methylheptadecyl hexadecanoate Chemical compound CCCCCCCCCCCCCCCC(=O)OCCCCCCCCCCCCCCCC(C)C SAMYFBLRCRWESN-UHFFFAOYSA-N 0.000 description 1
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical class C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- IELOKBJPULMYRW-IKTKBOKFSA-N 4-oxo-4-[[(2S)-2,5,7,8-tetramethyl-2-[(4S,8S)-4,8,12-trimethyltridecyl]-3,4-dihydrochromen-6-yl]oxy]butanoic acid Chemical compound CC(C)CCC[C@H](C)CCC[C@H](C)CCC[C@@](C)(CC1)Oc(c(C)c2C)c1c(C)c2OC(CCC(O)=O)=O IELOKBJPULMYRW-IKTKBOKFSA-N 0.000 description 1
- SQDAZGGFXASXDW-UHFFFAOYSA-N 5-bromo-2-(trifluoromethoxy)pyridine Chemical compound FC(F)(F)OC1=CC=C(Br)C=N1 SQDAZGGFXASXDW-UHFFFAOYSA-N 0.000 description 1
- ODHCTXKNWHHXJC-VKHMYHEASA-N 5-oxo-L-proline Chemical compound OC(=O)[C@@H]1CCC(=O)N1 ODHCTXKNWHHXJC-VKHMYHEASA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- 240000002234 Allium sativum Species 0.000 description 1
- 241001116389 Aloe Species 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000020518 Carthamus tinctorius Species 0.000 description 1
- 235000003255 Carthamus tinctorius Nutrition 0.000 description 1
- 229920001287 Chondroitin sulfate Polymers 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 244000180278 Copernicia prunifera Species 0.000 description 1
- 235000010919 Copernicia prunifera Nutrition 0.000 description 1
- 244000124209 Crocus sativus Species 0.000 description 1
- 235000015655 Crocus sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- GZIFEOYASATJEH-UHFFFAOYSA-N D-delta tocopherol Natural products OC1=CC(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 GZIFEOYASATJEH-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 235000004866 D-panthenol Nutrition 0.000 description 1
- 239000011703 D-panthenol Substances 0.000 description 1
- 235000001815 DL-alpha-tocopherol Nutrition 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 244000061508 Eriobotrya japonica Species 0.000 description 1
- 235000009008 Eriobotrya japonica Nutrition 0.000 description 1
- 241001553290 Euphorbia antisyphilitica Species 0.000 description 1
- 108010024636 Glutathione Proteins 0.000 description 1
- 241000546188 Hypericum Species 0.000 description 1
- 235000017309 Hypericum perforatum Nutrition 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- 244000280244 Luffa acutangula Species 0.000 description 1
- 235000009814 Luffa aegyptiaca Nutrition 0.000 description 1
- 240000000982 Malva neglecta Species 0.000 description 1
- 235000000060 Malva neglecta Nutrition 0.000 description 1
- 241000475481 Nebula Species 0.000 description 1
- 241000596467 Ononis Species 0.000 description 1
- WYWZRNAHINYAEF-UHFFFAOYSA-N Padimate O Chemical compound CCCCC(CC)COC(=O)C1=CC=C(N(C)C)C=C1 WYWZRNAHINYAEF-UHFFFAOYSA-N 0.000 description 1
- 244000170916 Paeonia officinalis Species 0.000 description 1
- 235000006484 Paeonia officinalis Nutrition 0.000 description 1
- 235000019482 Palm oil Nutrition 0.000 description 1
- 235000019483 Peanut oil Nutrition 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 244000184734 Pyrus japonica Species 0.000 description 1
- MJNIWUJSIGSWKK-BBANNHEPSA-N Riboflavin butyrate Chemical compound CCCC(=O)OC[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)[C@@H](OC(=O)CCC)CN1C2=CC(C)=C(C)C=C2N=C2C1=NC(=O)NC2=O MJNIWUJSIGSWKK-BBANNHEPSA-N 0.000 description 1
- 235000019774 Rice Bran oil Nutrition 0.000 description 1
- 244000178231 Rosmarinus officinalis Species 0.000 description 1
- 241001647091 Saxifraga granulata Species 0.000 description 1
- 244000044822 Simmondsia californica Species 0.000 description 1
- 235000004433 Simmondsia californica Nutrition 0.000 description 1
- 229920002385 Sodium hyaluronate Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 1
- MSCCTZZBYHQMQJ-AZAGJHQNSA-N Tocopheryl nicotinate Chemical compound C([C@@](OC1=C(C)C=2C)(C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)CC1=C(C)C=2OC(=O)C1=CC=CN=C1 MSCCTZZBYHQMQJ-AZAGJHQNSA-N 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- MECHNRXZTMCUDQ-UHFFFAOYSA-N Vitamin D2 Natural products C1CCC2(C)C(C(C)C=CC(C)C(C)C)CCC2C1=CC=C1CC(O)CCC1=C MECHNRXZTMCUDQ-UHFFFAOYSA-N 0.000 description 1
- 229930003427 Vitamin E Natural products 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- DFPAKSUCGFBDDF-ZQBYOMGUSA-N [14c]-nicotinamide Chemical compound N[14C](=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-ZQBYOMGUSA-N 0.000 description 1
- PAUSGZCRNOTKPK-UHFFFAOYSA-N [5-hydroxy-6-methyl-4-(octanoyloxymethyl)pyridin-3-yl]methyl octanoate Chemical compound CCCCCCCC(=O)OCC1=CN=C(C)C(O)=C1COC(=O)CCCCCCC PAUSGZCRNOTKPK-UHFFFAOYSA-N 0.000 description 1
- 239000006096 absorbing agent Substances 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 238000005377 adsorption chromatography Methods 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 235000011399 aloe vera Nutrition 0.000 description 1
- TUFYVOCKVJOUIR-UHFFFAOYSA-N alpha-Thujaplicin Natural products CC(C)C=1C=CC=CC(=O)C=1O TUFYVOCKVJOUIR-UHFFFAOYSA-N 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 125000003289 ascorbyl group Chemical class [H]O[C@@]([H])(C([H])([H])O*)[C@@]1([H])OC(=O)C(O*)=C1O* 0.000 description 1
- 235000021302 avocado oil Nutrition 0.000 description 1
- 239000008163 avocado oil Substances 0.000 description 1
- 235000013871 bee wax Nutrition 0.000 description 1
- 235000015278 beef Nutrition 0.000 description 1
- 239000012166 beeswax Substances 0.000 description 1
- 229950004580 benzyl nicotinate Drugs 0.000 description 1
- 229960002685 biotin Drugs 0.000 description 1
- 235000020958 biotin Nutrition 0.000 description 1
- 239000011616 biotin Substances 0.000 description 1
- PJDFMXWUFDUYTG-UHFFFAOYSA-N bis(2-hydroxyethyl)azanium;hexadecyl sulfate Chemical compound OCCNCCO.CCCCCCCCCCCCCCCCOS(O)(=O)=O PJDFMXWUFDUYTG-UHFFFAOYSA-N 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 229940082483 carnauba wax Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- RLGQACBPNDBWTB-UHFFFAOYSA-N cetyltrimethylammonium ion Chemical compound CCCCCCCCCCCCCCCC[N+](C)(C)C RLGQACBPNDBWTB-UHFFFAOYSA-N 0.000 description 1
- 150000001841 cholesterols Chemical class 0.000 description 1
- 229940059329 chondroitin sulfate Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 239000003086 colorant Substances 0.000 description 1
- 230000000052 comparative effect Effects 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000010389 delta-tocopherol Nutrition 0.000 description 1
- 229960000633 dextran sulfate Drugs 0.000 description 1
- GUJOJGAPFQRJSV-UHFFFAOYSA-N dialuminum;dioxosilane;oxygen(2-);hydrate Chemical compound O.[O-2].[O-2].[O-2].[Al+3].[Al+3].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O GUJOJGAPFQRJSV-UHFFFAOYSA-N 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229940124274 edetate disodium Drugs 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 238000004945 emulsification Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 229960002061 ergocalciferol Drugs 0.000 description 1
- XRLCQRMNGQRGOC-MDZDMXLPSA-N ethyl (e)-3-[2,4-di(propan-2-yl)phenyl]prop-2-enoate Chemical compound CCOC(=O)\C=C\C1=CC=C(C(C)C)C=C1C(C)C XRLCQRMNGQRGOC-MDZDMXLPSA-N 0.000 description 1
- 235000019162 flavin adenine dinucleotide Nutrition 0.000 description 1
- 239000011714 flavin adenine dinucleotide Substances 0.000 description 1
- VWWQXMAJTJZDQX-UYBVJOGSSA-N flavin adenine dinucleotide Chemical compound C1=NC2=C(N)N=CN=C2N1[C@@H]([C@H](O)[C@@H]1O)O[C@@H]1CO[P@](O)(=O)O[P@@](O)(=O)OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C2=NC(=O)NC(=O)C2=NC2=C1C=C(C)C(C)=C2 VWWQXMAJTJZDQX-UYBVJOGSSA-N 0.000 description 1
- 229940093632 flavin-adenine dinucleotide Drugs 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- FODTZLFLDFKIQH-FSVGXZBPSA-N gamma-Oryzanol (TN) Chemical compound C1=C(O)C(OC)=CC(\C=C\C(=O)O[C@@H]2C([C@@H]3CC[C@H]4[C@]5(C)CC[C@@H]([C@@]5(C)CC[C@@]54C[C@@]53CC2)[C@H](C)CCC=C(C)C)(C)C)=C1 FODTZLFLDFKIQH-FSVGXZBPSA-N 0.000 description 1
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 1
- 235000004611 garlic Nutrition 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229960003180 glutathione Drugs 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 125000003976 glyceryl group Chemical group [H]C([*])([H])C(O[H])([H])C(O[H])([H])[H] 0.000 description 1
- 229940075507 glyceryl monostearate Drugs 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical class O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 239000003906 humectant Substances 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- VLHZUYUOEGBBJB-UHFFFAOYSA-N hydroxy stearic acid Natural products OCCCCCCCCCCCCCCCCCC(O)=O VLHZUYUOEGBBJB-UHFFFAOYSA-N 0.000 description 1
- 229940113915 isostearyl palmitate Drugs 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- AHXDSVSZEZHDLV-UHFFFAOYSA-N mesulfen Chemical compound CC1=CC=C2SC3=CC(C)=CC=C3SC2=C1 AHXDSVSZEZHDLV-UHFFFAOYSA-N 0.000 description 1
- 229960005479 mesulfen Drugs 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000011812 mixed powder Substances 0.000 description 1
- 239000001788 mono and diglycerides of fatty acids Substances 0.000 description 1
- 229910052901 montmorillonite Inorganic materials 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- 125000000740 n-pentyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- 229920005615 natural polymer Polymers 0.000 description 1
- 229930014626 natural product Natural products 0.000 description 1
- 150000002814 niacins Chemical class 0.000 description 1
- 229960003966 nicotinamide Drugs 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- 229940060184 oil ingredients Drugs 0.000 description 1
- 239000002674 ointment Substances 0.000 description 1
- BARWIPMJPCRCTP-UHFFFAOYSA-N oleic acid oleyl ester Natural products CCCCCCCCC=CCCCCCCCCOC(=O)CCCCCCCC=CCCCCCCCC BARWIPMJPCRCTP-UHFFFAOYSA-N 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- BARWIPMJPCRCTP-CLFAGFIQSA-N oleyl oleate Chemical compound CCCCCCCC\C=C/CCCCCCCCOC(=O)CCCCCCC\C=C/CCCCCCCC BARWIPMJPCRCTP-CLFAGFIQSA-N 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 235000019161 pantothenic acid Nutrition 0.000 description 1
- 150000002948 pantothenic acids Chemical class 0.000 description 1
- 239000000312 peanut oil Substances 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 210000002826 placenta Anatomy 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 229960004172 pyridoxine hydrochloride Drugs 0.000 description 1
- 235000019171 pyridoxine hydrochloride Nutrition 0.000 description 1
- 239000011764 pyridoxine hydrochloride Substances 0.000 description 1
- 229940079889 pyrrolidonecarboxylic acid Drugs 0.000 description 1
- 239000002994 raw material Substances 0.000 description 1
- 239000011347 resin Substances 0.000 description 1
- 229920005989 resin Polymers 0.000 description 1
- 235000020944 retinol Nutrition 0.000 description 1
- 239000011607 retinol Substances 0.000 description 1
- 229960003471 retinol Drugs 0.000 description 1
- 229960000342 retinol acetate Drugs 0.000 description 1
- 239000011770 retinyl acetate Substances 0.000 description 1
- 235000019173 retinyl acetate Nutrition 0.000 description 1
- QGNJRVVDBSJHIZ-QHLGVNSISA-N retinyl acetate Chemical compound CC(=O)OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C QGNJRVVDBSJHIZ-QHLGVNSISA-N 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 239000008165 rice bran oil Substances 0.000 description 1
- 229940109850 royal jelly Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000013974 saffron Nutrition 0.000 description 1
- 239000004248 saffron Substances 0.000 description 1
- 235000020752 sage extract Nutrition 0.000 description 1
- 229940112950 sage extract Drugs 0.000 description 1
- 229940058287 salicylic acid derivative anticestodals Drugs 0.000 description 1
- 150000003872 salicylic acid derivatives Chemical class 0.000 description 1
- 238000010898 silica gel chromatography Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 235000010352 sodium erythorbate Nutrition 0.000 description 1
- 239000004320 sodium erythorbate Substances 0.000 description 1
- GCLGEJMYGQKIIW-UHFFFAOYSA-H sodium hexametaphosphate Chemical compound [Na]OP1(=O)OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])OP(=O)(O[Na])O1 GCLGEJMYGQKIIW-UHFFFAOYSA-H 0.000 description 1
- 235000019982 sodium hexametaphosphate Nutrition 0.000 description 1
- 229940010747 sodium hyaluronate Drugs 0.000 description 1
- RBWSWDPRDBEWCR-RKJRWTFHSA-N sodium;(2r)-2-[(2r)-3,4-dihydroxy-5-oxo-2h-furan-2-yl]-2-hydroxyethanolate Chemical compound [Na+].[O-]C[C@@H](O)[C@H]1OC(=O)C(O)=C1O RBWSWDPRDBEWCR-RKJRWTFHSA-N 0.000 description 1
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 1
- NWZBFJYXRGSRGD-UHFFFAOYSA-M sodium;octadecyl sulfate Chemical compound [Na+].CCCCCCCCCCCCCCCCCCOS([O-])(=O)=O NWZBFJYXRGSRGD-UHFFFAOYSA-M 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 229960005078 sorbitan sesquioleate Drugs 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 210000000434 stratum corneum Anatomy 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- 239000003760 tallow Substances 0.000 description 1
- 239000001577 tetrasodium phosphonato phosphate Substances 0.000 description 1
- 239000002562 thickening agent Substances 0.000 description 1
- 229910052719 titanium Inorganic materials 0.000 description 1
- 239000010936 titanium Substances 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229940111029 tocopherol,dl-alpha Drugs 0.000 description 1
- 229950009883 tocopheryl nicotinate Drugs 0.000 description 1
- LOIYMIARKYCTBW-OWOJBTEDSA-N trans-urocanic acid Chemical compound OC(=O)\C=C\C1=CNC=N1 LOIYMIARKYCTBW-OWOJBTEDSA-N 0.000 description 1
- LOIYMIARKYCTBW-UHFFFAOYSA-N trans-urocanic acid Natural products OC(=O)C=CC1=CNC=N1 LOIYMIARKYCTBW-UHFFFAOYSA-N 0.000 description 1
- 235000019164 vitamin B2 Nutrition 0.000 description 1
- 239000011716 vitamin B2 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- MECHNRXZTMCUDQ-RKHKHRCZSA-N vitamin D2 Chemical compound C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)/C=C/[C@H](C)C(C)C)=C\C=C1\C[C@@H](O)CCC1=C MECHNRXZTMCUDQ-RKHKHRCZSA-N 0.000 description 1
- 235000001892 vitamin D2 Nutrition 0.000 description 1
- 239000011653 vitamin D2 Substances 0.000 description 1
- 229940046009 vitamin E Drugs 0.000 description 1
- 235000019165 vitamin E Nutrition 0.000 description 1
- 239000011709 vitamin E Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000002087 whitening effect Effects 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- 229930007845 β-thujaplicin Natural products 0.000 description 1
- 239000002446 δ-tocopherol Substances 0.000 description 1
Abstract
Description
【0001】0001
【産業上の利用分野】本発明は皮膚外用剤、さらに詳し
くは肌荒れ防止、肌荒れ改善のほか、皮膚のたるみ、つ
やの消失などを防いで老化を防止する効果の高い皮膚外
用剤に関する。FIELD OF THE INVENTION The present invention relates to a skin preparation for external use, and more particularly to a skin preparation for external use that is highly effective in preventing and improving skin roughness, as well as preventing skin sagging and loss of luster, thereby preventing aging.
【0002】0002
【従来の技術】従来、天然物から抽出した各種原料、た
とえばタンパク質、多糖、抽出エキス、天然高分子等が
、その使用効果が特徴的であるため皮膚外用剤に配合さ
れてきたが、その効果はいまだ十分でなく効果を期待す
るにはおよばなかった。[Prior Art] Conventionally, various raw materials extracted from natural products, such as proteins, polysaccharides, extracted extracts, natural polymers, etc., have been blended into external skin preparations because of their distinctive effects. However, the results were still insufficient and the effects were not as high as expected.
【0003】0003
【発明が解決しようとする課題】本発明者らは肌荒れ防
止、肌荒れ改善、皮膚のたるみ、つやの消失なとを防い
で老化を防止する効果を高める方法はないものかと鋭意
研究した結果、シソ科メリッサ属植物抽出物と、ビタミ
ン類からの一種または二種以上とを配合することによっ
て、この目的が達成できることを見出して本発明を完成
するに至った。[Problems to be Solved by the Invention] The present inventors have conducted extensive research to find a method for preventing skin roughness, improving skin roughness, preventing skin sagging, loss of luster, and increasing the effect of preventing aging. The present invention has been completed based on the discovery that this object can be achieved by blending a plant extract of the genus Melissa with one or more vitamins.
【0004】0004
【課題を解決するための手段】すなわち、本発明はシソ
科メリッサ属植物抽出物と、ビタミン類の一種または二
種以上とを配合することを特徴とする皮膚外用剤を提供
するものである。以下、本発明の構成について詳述する
。本発明に使用されるシソ科メリッサ属植物はメリッサ
等である。これらは一般的に葉を用いるが、果実、樹皮
も用いられる。本発明で用いるシソ科メリッサ属植物抽
出物の抽出方法は常法に従って行えば良いが、一例を挙
げると次の通りである。[Means for Solving the Problems] That is, the present invention provides a skin preparation for external use, which is characterized in that it contains an extract of a plant belonging to the Lamiaceae family, the genus Melissa, and one or more vitamins. Hereinafter, the configuration of the present invention will be explained in detail. The plants of the genus Melissa of the Lamiaceae family used in the present invention include Melissa officinalis. These generally use leaves, but fruits and bark are also used. The extraction method for the plant extract of the Lamiaceae genus Melissa used in the present invention may be carried out according to a conventional method, and an example is as follows.
【0005】抽出法は、溶媒、例えば水、ジプロピレン
グリコールや1,3−ブチレングリコール等の多価アル
コールまたはそれらの混合物でシソ科メリッサ属植物を
加熱還流し、濾過して得ることでき、一般にはこの抽出
液を濃縮して使用する。別の方法として、上記した方法
で抽出して得られる抽出物をシリカゲルクロマトグラフ
ィーなどの吸着系クロマトグラフィーを用いて分画して
得られる抽出物を用いることもできる。[0005] In the extraction method, a plant of the genus Melissa of the Lamiaceae family is heated under reflux in a solvent such as water, a polyhydric alcohol such as dipropylene glycol or 1,3-butylene glycol, or a mixture thereof, and then filtered. This extract is concentrated and used. Alternatively, an extract obtained by fractionating the extract obtained by the above-described method using adsorption chromatography such as silica gel chromatography can also be used.
【0006】本発明においてシソ科メリッサ属植物を抽
出液として配合する場合、あるいは分画抽出物として配
合する場合の配合量は皮膚外用剤全量中、0.0001
〜30重量%、好ましくは0.005〜15重量%であ
る。0.0001重量%未満ではその効果は発揮されず
、30重量%を越えると製品の製造工程上好ましくない
。[0006] In the present invention, when a plant of the genus Melissa of the Lamiaceae family is blended as an extract or as a fractionated extract, the blending amount is 0.0001 in the total amount of the skin external preparation.
-30% by weight, preferably 0.005-15% by weight. If it is less than 0.0001% by weight, the effect will not be exhibited, and if it exceeds 30% by weight, it is unfavorable in terms of the manufacturing process of the product.
【0007】本発明で用いられるビタミン類は、ビタミ
ンA油、レチノール、酢酸レチノールなどのビタミンA
類、リボフラビン、酪酸リボフラビン、フラビンアデニ
ンジヌクレオチドなどのビタミンB2類、ピリドキシン
塩酸塩、ピリドキシントリパルミテート、ピリドキシン
ジオクタノエー卜等のビタミンB6類、バントテン酸カ
ルシウム、D−パントテニルアルコール、パントテニル
エチルエーテル、アセチルパントテニルエチルエーテル
等のパントテン酸類、イノシット、エルゴカルシフェロ
ール、コレカルシフェロール、ニコチン酸、ニコチン酸
アミド、ニコチン酸ベンジル等のニコチン酸類、α−ト
コフェロール、δ−トコフェロール、酢酸DL−α−ト
コフェロール、ニコチン酸DL−α−トコフェロール、
コハク酸DL−α−トコフェロール等のビタミンE類.
ビオチン等がある。[0007] The vitamins used in the present invention include vitamin A oil, retinol, retinol acetate, etc.
vitamin B2 such as riboflavin, riboflavin butyrate, flavin adenine dinucleotide, vitamin B6 such as pyridoxine hydrochloride, pyridoxine tripalmitate, pyridoxine dioctanoate, calcium bantothenate, D-pantothenyl alcohol, pantotenyl Pantothenic acids such as ethyl ether and acetyl pantothenyl ethyl ether, nicotinic acids such as inosit, ergocalciferol, cholecalciferol, nicotinic acid, nicotinamide, benzyl nicotinate, α-tocopherol, δ-tocopherol, DL-α acetate -tocopherol, DL-α-tocopherol nicotinic acid,
Vitamin E such as DL-α-tocopherol succinate.
Biotin etc.
【0008】本発明におけるビタミン類の配合量には特
に限定はないが、好ましくは皮膚外用剤全量中に、0.
005〜10重量%さらに好ましくは、0.01〜5重
量%配合される。ビタミン類の皮膚外用剤への配合量は
、シソ科メリッサ属植物抽出液や抽出物に対して重量で
1/100倍量以上、好ましくは、1/10倍量以上で
ある。[0008] There is no particular limitation on the amount of vitamins to be blended in the present invention, but preferably 0.
0.05 to 10% by weight, more preferably 0.01 to 5% by weight. The amount of vitamins to be added to the skin external preparation is 1/100 times or more, preferably 1/10 times or more by weight of the extract or extract of a plant belonging to the genus Melissa of the Lamiaceae family.
【0009】本発明の皮膚外用剤には上記した必須成分
の他に通常化粧品や医薬品等の皮膚外用剤に用いられる
他の成分、例えばアボガド油、パーム油、ピーナッツ油
、牛脂、コメヌカ油、ホホバ油、カルナバロウ、ラノリ
ン、流動パラフィン、オキシステアリン酸、パルミチン
酸イソステアリル、イソステアリルアルコール等の油分
、グリセリン、ソルビトール、ポリエチレングリコール
、ピロリドンカルボン酸およびその塩、コラーゲン、ヒ
アルロン酸およびその塩、コンドロイチン硫酸およびそ
の塩等の保湿剤、パラジメチルアミノ安息香酸アミル、
ウロカニン酸、ジイソプロピルケイヒ酸エチル等の紫外
線吸収剤、エリソルビン酸ナトリウム、セージエキス、
パラヒドロキシアニソール等の酸化防止剤、ステアリル
硫酸ナトリウム、セチル硫酸ジエタノールアミン、セチ
ルトリメチルアンモニウムサッカリン、イソステアリン
酸ポリエチレングリコール、アラキン酸グリセリル等の
界面活性剤、エチルバラベン、ブチルバラベン等の防腐
剤、オウバク、オウレン、シコン、シャクヤク、センブ
リ、バーチ、ビワ等の抽出物、グリチルリチン酸誘導体
、グリチルレチン酸誘導体、サリチル酸誘導体、ヒノキ
チオール、酸化亜鉛、アラントイン等の消炎剤、胎盤抽
出物、グルタチオン、ユキノシタ抽出物、アスコルビン
酸誘導体等の美白剤、ニンジン、アロエ、ゼニアオイ、
アイリス、ブドウ、ヨクイニン、ヘチマ、ユリ等の抽出
物、ローヤルゼリー、感光素、コレステロール誘導体、
各種アミノ酸類等の賦活剤、サフラン、センキュウ、シ
ョウキョウ、オトギリソウ、オノニス、ローズマリー、
ニンニク等の抽出物、γ−オリザノール、デキストラン
硫酸ナトリウム、等の血行促進剤、硫黄、チアントール
等の抗脂漏剤、香料、水、アルコール、カルボキシビニ
ルポリマー等の増粘剤、チタンイエロー、カーサミン、
ベニバナ赤等の色剤等を必要に応じて適宜配合すること
ができる。[0009] In addition to the above-mentioned essential ingredients, the external skin preparation of the present invention contains other ingredients normally used in external skin preparations such as cosmetics and pharmaceuticals, such as avocado oil, palm oil, peanut oil, beef tallow, rice bran oil, and jojoba. Oil, carnauba wax, lanolin, liquid paraffin, oxystearic acid, isostearyl palmitate, isostearyl alcohol and other oils, glycerin, sorbitol, polyethylene glycol, pyrrolidone carboxylic acid and its salts, collagen, hyaluronic acid and its salts, chondroitin sulfate and Humectants such as its salts, amyl paradimethylaminobenzoate,
Ultraviolet absorbers such as urocanic acid, ethyl diisopropyl cinnamate, sodium erythorbate, sage extract,
Antioxidants such as parahydroxyanisole, sodium stearyl sulfate, diethanolamine cetyl sulfate, cetyltrimethylammonium saccharin, polyethylene glycol isostearate, surfactants such as glyceryl arachiate, preservatives such as ethylbaraben, butylbaraben, auricularis, oren, Extracts of Chinese citrus, peony, Japanese japonica, birch, loquat, etc., anti-inflammatory agents such as glycyrrhizinic acid derivatives, glycyrrhetinic acid derivatives, salicylic acid derivatives, hinokitiol, zinc oxide, allantoin, placenta extract, glutathione, saxifrage extract, ascorbic acid derivatives, etc. whitening agent, carrot, aloe, mallow,
Extracts of iris, grape, lily, loofah, lily, etc., royal jelly, photosensor, cholesterol derivative,
Activators such as various amino acids, saffron, nebula, ginger, hypericum, ononis, rosemary,
Extracts such as garlic, blood circulation promoters such as γ-oryzanol and sodium dextran sulfate, antiseborrheic agents such as sulfur and thianthol, fragrances, water, alcohol, thickeners such as carboxyvinyl polymer, titanium yellow, cursamine,
A coloring agent such as safflower red may be appropriately blended as necessary.
【0010】本発明の皮膚外用剤の剤型は任意であり、
溶液系、可溶化系、乳化系、粉未分散系、水−油二層系
、水−油−粉末三層系等、どのような剤型でも構わない
。また、本発明の皮膚外用剤の用途も任意であり、化粧
水、乳液、クリーム、パック等のフェーシャル化粧料や
ファンデーション、口紅、アイシャドー等のメーキャッ
プ化粧料やボディー化粧料、芳香化粧料、洗浄料、軟膏
等に用いることができる。[0010] The dosage form of the skin external preparation of the present invention is arbitrary;
Any dosage form may be used, such as a solution system, a solubilized system, an emulsification system, an undispersed powder system, a water-oil two-layer system, a water-oil-powder three-layer system, etc. In addition, the use of the skin external preparation of the present invention is arbitrary, and it can be used in facial cosmetics such as lotions, milky lotions, creams, and packs, makeup cosmetics such as foundations, lipsticks, and eye shadows, body cosmetics, aromatic cosmetics, and cleaning products. It can be used in creams, ointments, etc.
【0011】[0011]
【実施例】つぎに実施例および比較例をあげて、本発明
を具体的に明らかにする。本発明はこれにより限定され
るものではない。配台量は重量%である。
試験例1
下記の処方のクリームにおいて、メリッサ抽出液*を0
重量%、5重量%、酢酸DL−α−トコフェロールを0
重量%、0.5重量%と変化させたクリームで人体パネ
ルで肌荒れ防止および肌荒れ改善効果試験を行った。す
なわち、女性健康人(顔面)の皮膚表面形態をミリスチ
ン樹脂によるレプリカ法を用いて肌のレプリカを採り顕
微鏡(17倍)にて観察する。[Examples] Next, Examples and Comparative Examples will be given to specifically clarify the present invention. The present invention is not limited thereby. The arrangement amount is weight %. Test Example 1 In the cream with the following formulation, 0 melissa extract* was added.
wt%, 5 wt%, 0 DL-α-tocopherol acetate
A skin roughness prevention and skin improvement effect test was conducted on a human body panel using creams with varying amounts of 0.5% and 0.5% by weight. That is, a skin replica of the skin surface morphology of a healthy female person (face) is taken using a replica method using myristic resin and observed under a microscope (17x magnification).
【0012】皮紋の状態および角層の剥離状態から表−
1に示す基準に基づいて肌荒れ評価1、2と判断された
者(肌荒れパネル)30名を用い、顔面左右半々に、実
施例1で得たクリームとメリッサ抽出液を配合しないク
リーム又は酢酸DL−α−トコフェロールを配合しない
クリームを1日2回塗布した。2週間後再びレプリカを
採り肌の状態を観察し、表−1の判断基準に従って評価
した。[0012] From the condition of the skin pattern and the peeling condition of the stratum corneum -
Thirty people (skin panel) who were judged to have a skin roughness rating of 1 or 2 based on the criteria shown in Example 1 were given the cream obtained in Example 1, a cream without Melissa extract, or acetic acid DL- on the left and right half of their faces. A cream containing no α-tocopherol was applied twice a day. Two weeks later, a replica was taken again and the condition of the skin was observed and evaluated according to the criteria in Table 1.
【0013】*製法 メリッサの葉100gを充分水
洗し、これに、50%の1,3−ブチレングリコール水
溶液1.2kgおよびパラオキシ安息香酸メチル2.4
gを加え、室温にて10日間浸漬する。この抽出液を濾
過し、メリッサ抽出液を得る。
A.
セタノール
0.5% ワセリン
2.0
スクワラン
7.0 自己乳化型モノステアリン
酸グリセリン
2.5 ポリオキシエチレンソルビタ
ンモノステアリン酸エステル(20EO)
1.5 パントテニルエチルエーテ
ル
0.5 ホホバ油
5.
0 酢酸−DL−α−トコフェロール
0.5または0
B.
プロピレングリコール
5.0 グリセリン
5.0 ビーガム
(モンモリロナイト)
5.0 メ
リッサ抽出液
5ま
たは0 水酸化カリウム
0.3 水
残余 −製法−
A(油相)とB(水相)をそれぞれ70℃に加熱し
、完全溶解する。AをBに加えて、乳化機で乳化する。
乳化物を熱交換機を用いて冷却してクリームを得た。*Manufacturing method: Wash 100 g of Melissa leaves thoroughly with water, add 1.2 kg of 50% aqueous 1,3-butylene glycol solution and 2.4 ml of methyl paraoxybenzoate.
g and soaked at room temperature for 10 days. This extract is filtered to obtain a melissa extract. A. Setanol
0.5% Vaseline
2.0
Squalane
7.0 Self-emulsifying glyceryl monostearate
2.5 Polyoxyethylene sorbitan monostearate (20EO)
1.5 Pantothenyl ethyl ether
0.5 Jojoba oil
5.
0 Acetate-DL-α-tocopherol
0.5 or 0
B. Propylene glycol
5.0 Glycerin
5.0 Veegum (montmorillonite)
5.0 Melissa extract
5 or 0 potassium hydroxide
0.3 water
Residue - Manufacturing method - Heat A (oil phase) and B (aqueous phase) to 70°C to completely dissolve them. Add A to B and emulsify with an emulsifier. The emulsion was cooled using a heat exchanger to obtain cream.
【0014】[0014]
【表−1】[Table-1]
【0015】結果を表−2に示す[0015] The results are shown in Table 2.
【表−2】[Table-2]
【0016】この結果より酢酸DL−α−トコフェロー
ルとメリッサまたは抽出液を配合した化粧料を使用した
顔面部位は他の化粧料を使用した顔面部位と比較し、顕
著な肌荒れ防止・肌荒れ改善効果が認められた。[0016] The results show that facial areas using cosmetics containing DL-α-tocopherol acetate and melissa or extract have a remarkable effect on preventing and improving rough skin compared to facial areas using other cosmetics. Admitted.
【0017】実施例1 クリーム
A.ステアリン酸
10.0% ステアリルアルコール
4.0 ステアリン酸ブチル
8.0 ステア
リン酸モノグリセリンエステル
2.0 ビタミシE
アセテート
0.5
香料
0.4 防腐剤
適量B・メリッ
サ抽出液
30.0
グリセリン
4.0 水酸化カリウム
0.4 エデト
酸三ナトリウム
0.05
精製水
残余Aの油相部とBの水相部をそれぞ
れ70℃に加熱し完全溶解する。A相をB相に加えて、
乳化機で乳化する。乳化物を熱交換械を用いて冷却して
クリームを得た。Example 1 Cream A. stearic acid
10.0% stearyl alcohol
4.0 Butyl stearate
8.0 Stearic acid monoglycerol ester
2.0 Vitamishi E
acetate
0.5
fragrance
0.4 Preservative
Appropriate amount B. Melissa extract
30.0
glycerin
4.0 Potassium hydroxide
0.4 Trisodium edetate
0.05
purified water
The remaining oil phase portion of A and water phase portion of B are each heated to 70°C to completely dissolve them. Add phase A to phase B,
Emulsify with an emulsifying machine. The emulsion was cooled using a heat exchanger to obtain cream.
【0018】実施例2 クリーム
A.セタノール
4.0% ワセリン
7.0 イ
ソプロピルミリステート
8.0
スクワラン
15.0 ステアリン酸モノグリセリンエ
ステル
2.2 POE(20)ソルビタンモノステ
アレート 2.8
ビタミンEニコチネート
2.0 香料
0.3 酸化防止
剤
適
量 防腐剤
適量B.グリセリン
10.0 メリ
ッサ抽出液
0
.02 ジプロピレングリコール
4.0 ピロリドンカルボン酸ナトリウ
ム
1.0 エデト酸二ナトリウム
0.01 精製水
残余実
施例1に準じてクリームを得た。Example 2 Cream A. Setanol
4.0% Vaseline
7.0 Isopropyl myristate
8.0
Squalane
15.0 Stearic acid monoglycerol ester
2.2 POE(20) Sorbitan Monostearate 2.8
Vitamin E Nicotinate
2.0 Fragrance
0.3 Antioxidant
Appropriate amount preservative
Appropriate amountB. glycerin
10.0 Melissa extract
0
.. 02 Dipropylene glycol
4.0 Sodium pyrrolidone carboxylate
1.0 Edetate disodium
0.01 Purified water
A cream was obtained according to the rest of Example 1.
【0019】実施例3 乳液
A.スクワラン
5.0% オレイルオレート
3.0 ワセリン
2
.0 ソルビタンセスキオレイン酸エステル
0.8
ポリオキシエチレンオレイルエーテル(20E
O) 1.2 ビタミン
A油
0.
03 香料
0.3 防腐剤
適
量B.1,3ブチレングリコール
4
.5 メリッサ抽出液
1.5 ヒアルロン酸ナトリウム
0.5 エタノール
3.0
カルボキシビニルポルリマー
0.
2 水酸化カリウム
0.1 ヘキサメタリン酸ナトリウ
ム
0.05 精製水
残余実施
例1に準じて乳液を得た。Example 3 Emulsion A. Squalane
5.0% oleyl oleate
3.0 Vaseline
2
.. 0 Sorbitan sesquioleate
0.8
Polyoxyethylene oleyl ether (20E
O) 1.2 Vitamin A oil
0.
03 Fragrance
0.3 Preservative
Appropriate amountB. 1,3 butylene glycol
4
.. 5 Melissa extract
1.5 Sodium hyaluronate
0.5 ethanol
3.0
carboxyvinyl polymer
0.
2 Potassium hydroxide
0.1 Sodium hexametaphosphate
0.05 Purified water
A milky lotion was obtained according to the rest of Example 1.
【0020】実施例4 ファンデーションA.セタノ
ール
3.5% 脱臭ラノリン
4.0 ホホバ油
5.0
ワセリン
2.0 スクワラン
6.0 ス
テアリン酸モノグリセリンエステル
2.5 POE
(60)硬化ヒマシ油
1.5 P
OE(20)セチルエーテル
1.0
ピリドキシントリパルミテート
0.1
防腐剤
適量 香料
0.3B.プロ
ピレングリコール
10.0
メリッサ抽出物
0.1 調合粉末
12.0 エデト酸三
ナトリウム
0.2
精製水
残余実施例1に準じてファンデーションを得
た。Example 4 Foundation A. Setanol
3.5% deodorized lanolin
4.0 Jojoba oil
5.0
Vaseline
2.0 Squalane
6.0 Stearic acid monoglycerol ester
2.5 POE
(60) Hydrogenated castor oil
1.5 P
OE(20) Cetyl ether
1.0
Pyridoxine Tripalmitate
0.1
Preservative
Appropriate amount fragrance
0.3B. Propylene glycol
10.0
melissa extract
0.1 Mixed powder
12.0 Trisodium edetate
0.2
purified water
A foundation was obtained according to the rest of Example 1.
【0021】実施例5 化粧水
A.エタノール
5.0% POEオレイルアルコールエー
テル
2.0 2−エチルヘキシル−P−ジメチルア
ミノベンゾエート 0.18 香料
0.05B.1,3ブチレングリコール
9.5 ピロリドンカルボン酸ナトリウム
0
.1 メリッサ抽出液
5.0 ニコチン酸アミド
0.3 グリセリン
5.0
精製水
残余Aのアルコール相をBの水相に添加し、可溶
化して化粧水をえた。Example 5 Lotion A. ethanol
5.0% POE oleyl alcohol ether
2.0 2-ethylhexyl-P-dimethylaminobenzoate 0.18 Fragrance
0.05B. 1,3 butylene glycol
9.5 Sodium pyrrolidone carboxylate
0
.. 1 Melissa extract
5.0 Nicotinamide
0.3 Glycerin
5.0
purified water
The remaining alcohol phase of A was added to the aqueous phase of B and solubilized to obtain a lotion.
【0022】実施例6 パック
(1)ポリビニルアルコール
10.0%(2
)ポリエチレングリコール(分子量400)
0.4(3)グリセリン
3.0(4)エタノール(9
5%)
8.0(5)メリッサ抽出液
0.1(6)イノシット
0.1(7)防腐剤
0.1(8)
香料
0.1(9)精製水
残余室温で(4)(7)(8)を混合容解し
、(1)(2)(3)および(5)(6)(9)を80
℃で混合溶解した中に撹拌添加した後、室温まで放冷し
てパックを得た。Example 6 Pack (1) Polyvinyl alcohol
10.0% (2
) Polyethylene glycol (molecular weight 400)
0.4(3) Glycerin
3.0 (4) Ethanol (9
5%)
8.0 (5) Melissa extract
0.1 (6) Inosit
0.1 (7) Preservative
0.1 (8)
fragrance
0.1 (9) Purified water
Mix and dissolve (4), (7), and (8) at room temperature, and add (1), (2), (3), and (5), (6), and (9) to 80%
After stirring and adding the mixture to the solution mixed and dissolved at ℃, the mixture was allowed to cool to room temperature to obtain a pack.
【0023】実施例7 口紅
(1)ヒマシ油
2
0.0%(2)セチルアルコール
2
0.0(3)ミツロウ
5.0(4)キャンデリラロウ
30.0(5)メリッサ抽出液
2.0(6)スクワラン
13.0(7)カルナバロウ
5.0(8)顔料
5.0(9)コレカルシ
フェロール
0.01(10)香料
適量Example 7 Lipstick (1) Castor oil
2
0.0% (2) Cetyl alcohol
2
0.0 (3) Beeswax
5.0(4) Candelilla Row
30.0 (5) Melissa extract
2.0(6) Squalane
13.0(7) Carnauba Low
5.0(8) Pigment
5.0(9) Cholecalciferol
0.01 (10) Fragrance
Appropriate amount
【0024
】(1)〜(9)を80℃にて混合溶解し、型に流し込
んで室温まで放冷した後、型からとり出して棒状口紅を
得た。0024
] (1) to (9) were mixed and dissolved at 80°C, poured into a mold, allowed to cool to room temperature, and then taken out from the mold to obtain a lipstick stick.
【0025】[0025]
【発明の効果】本発明の皮膚外用剤は、ビタミン類を配
合することによりシソ科メリッサ属植物抽出物の持つ肌
荒れ防止肌荒れ改善効果、皮膚のたるみ、つやの消失な
どを防いで老化を防止する効果を副作用なく著しく増加
させることができる利点を持っている。[Effects of the Invention] The skin external preparation of the present invention has the effect of preventing rough skin and improving skin roughness, and the effect of preventing aging by preventing skin sagging and loss of luster, etc., of the extract of a plant belonging to the genus Melissa of the Lamiaceae family, by incorporating vitamins. It has the advantage of being able to increase significantly without side effects.
Claims (2)
ン類の一種または二種以上とを配合することを特徴とす
る皮膚外用剤[Claim 1] A skin external preparation characterized by containing an extract of a plant of the genus Melissa of the Lamiaceae family and one or more vitamins.
許請求範囲第1項記載の皮膚外用剤。2. The skin external preparation according to claim 1, wherein the plant of the genus Melissa of the Lamiaceae family is Melissa officinalis.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3142298A JPH04305512A (en) | 1991-03-29 | 1991-03-29 | External preparation for skin |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP3142298A JPH04305512A (en) | 1991-03-29 | 1991-03-29 | External preparation for skin |
Publications (1)
Publication Number | Publication Date |
---|---|
JPH04305512A true JPH04305512A (en) | 1992-10-28 |
Family
ID=15312129
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP3142298A Withdrawn JPH04305512A (en) | 1991-03-29 | 1991-03-29 | External preparation for skin |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPH04305512A (en) |
Cited By (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5415861A (en) * | 1991-07-01 | 1995-05-16 | Avon Products, Inc. | Composition and method for visibly reducing the size of skin pores |
WO1997039733A1 (en) * | 1996-04-23 | 1997-10-30 | The Procter & Gamble Company | Methods of regulating skin appearance with vitamin b3 compound |
JPH10175842A (en) * | 1996-12-13 | 1998-06-30 | Noevir Co Ltd | Skin preparation for external use |
JPH10182333A (en) * | 1996-12-20 | 1998-07-07 | Noevir Co Ltd | Antimicrobial and low-irritation cosmetic |
JPH10194915A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
JPH115727A (en) * | 1997-06-17 | 1999-01-12 | Pola Chem Ind Inc | Skin cosmetic |
FR2787997A1 (en) * | 1998-12-31 | 2000-07-07 | Obagi Europ | Multicomponent cosmetic product for rejuvenating the skin comprises a composition containing encapsulated hydroquinone and a composition containing lactic acid, glycolic acid and/or inositol |
US6183761B1 (en) | 1998-03-16 | 2001-02-06 | The Procter & Gamble Company | Compositions for regulating skin appearance |
US6224888B1 (en) | 1999-02-12 | 2001-05-01 | The Procter & Gamble Company | Cosmetic compositions |
US6238678B1 (en) | 1995-11-06 | 2001-05-29 | The Procter & Gamble Company | Methods of regulating skin appearance with vitamin B3 compound |
US6309657B2 (en) | 1999-02-12 | 2001-10-30 | The Procter & Gamble Company | Cosmetic compositions |
US6455055B1 (en) | 1999-02-12 | 2002-09-24 | The Procter & Gamble Company | Cosmetic compositions |
EP1349558A1 (en) * | 2000-12-12 | 2003-10-08 | Angiolab, Inc. | Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
JP2008007411A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Transglutaminase production promoter and epidermal keratinization-normalizing agent |
-
1991
- 1991-03-29 JP JP3142298A patent/JPH04305512A/en not_active Withdrawn
Cited By (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5472699A (en) * | 1991-07-01 | 1995-12-05 | Avon Products, Inc. | Composition and method for visibly reducing the size of skin pores |
US5415861A (en) * | 1991-07-01 | 1995-05-16 | Avon Products, Inc. | Composition and method for visibly reducing the size of skin pores |
US6238678B1 (en) | 1995-11-06 | 2001-05-29 | The Procter & Gamble Company | Methods of regulating skin appearance with vitamin B3 compound |
WO1997039733A1 (en) * | 1996-04-23 | 1997-10-30 | The Procter & Gamble Company | Methods of regulating skin appearance with vitamin b3 compound |
JPH11508281A (en) * | 1996-04-23 | 1999-07-21 | ザ、プロクター、エンド、ギャンブル、カンパニー | How to adjust the appearance of skin with Vitamin B compounds |
JPH10175842A (en) * | 1996-12-13 | 1998-06-30 | Noevir Co Ltd | Skin preparation for external use |
JPH10182333A (en) * | 1996-12-20 | 1998-07-07 | Noevir Co Ltd | Antimicrobial and low-irritation cosmetic |
JPH10194915A (en) * | 1997-01-14 | 1998-07-28 | Noevir Co Ltd | Antimicrobial and low-irritating cosmetic |
JPH115727A (en) * | 1997-06-17 | 1999-01-12 | Pola Chem Ind Inc | Skin cosmetic |
US6183761B1 (en) | 1998-03-16 | 2001-02-06 | The Procter & Gamble Company | Compositions for regulating skin appearance |
FR2787997A1 (en) * | 1998-12-31 | 2000-07-07 | Obagi Europ | Multicomponent cosmetic product for rejuvenating the skin comprises a composition containing encapsulated hydroquinone and a composition containing lactic acid, glycolic acid and/or inositol |
US6224888B1 (en) | 1999-02-12 | 2001-05-01 | The Procter & Gamble Company | Cosmetic compositions |
US6309657B2 (en) | 1999-02-12 | 2001-10-30 | The Procter & Gamble Company | Cosmetic compositions |
US6455055B1 (en) | 1999-02-12 | 2002-09-24 | The Procter & Gamble Company | Cosmetic compositions |
US6528071B2 (en) | 1999-02-12 | 2003-03-04 | The Procter & Gamble Company | Cosmetic compositions |
EP1349558A1 (en) * | 2000-12-12 | 2003-10-08 | Angiolab, Inc. | Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
EP1349558A4 (en) * | 2000-12-12 | 2004-03-24 | Angiolab Inc | Composition comprising melissa leaf extract for anti-angiogenic and matrix metalloproteinase inhibitory activity |
JP2008007411A (en) * | 2006-06-27 | 2008-01-17 | Maruzen Pharmaceut Co Ltd | Transglutaminase production promoter and epidermal keratinization-normalizing agent |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JPH04305512A (en) | External preparation for skin | |
JP2002080338A (en) | Antiaging skin care preparation | |
JPS6248611A (en) | External preparation for skin | |
JPH11263720A (en) | Antiaging agent | |
JP4070065B2 (en) | Skin preparation for preventing and improving skin roughness | |
JP2002003373A (en) | Skin care preparation | |
JP2002003358A (en) | Skin care preparation | |
JP2000086486A (en) | Skin preparation for external use | |
JPH10279418A (en) | Preparation for external use for skin | |
JPH10279419A (en) | Preparation for external use for skin | |
JPH09118612A (en) | Skin preparation for external use | |
JPH09286709A (en) | Preparation for external use for skin | |
JP3093353B2 (en) | External preparation for skin | |
JP2002128632A (en) | Cosmetic | |
JPH05194175A (en) | Cosmetic | |
JPH04321616A (en) | Skin medicine for external use | |
JP3519233B2 (en) | External preparation for skin | |
JP2000086483A (en) | Skin preparation for external use | |
JPH10203921A (en) | Skin preparation for external use | |
JP2003238429A (en) | Fibroblast cell-activating agent and skin external agent containing the same | |
JPS63174911A (en) | External drug for skin | |
JPH10259113A (en) | Skin preparation for external use | |
JP2000063226A (en) | Skin preparation for external use | |
JPH10273416A (en) | Skin preparation for external use | |
JPS61254510A (en) | External agent for skin |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A300 | Application deemed to be withdrawn because no request for examination was validly filed |
Free format text: JAPANESE INTERMEDIATE CODE: A300 Effective date: 19980514 |